Extrapulmonary Small Cell Carcinoma: An Unfortunate Case of Metastatic Disease.

Clin Gastroenterol Hepatol

Pathology Department, Sharp Medical Group, San Diego, California.

Published: February 2019

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2017.12.049DOI Listing

Publication Analysis

Top Keywords

extrapulmonary small
4
small cell
4
cell carcinoma
4
carcinoma unfortunate
4
unfortunate case
4
case metastatic
4
metastatic disease
4
extrapulmonary
1
cell
1
carcinoma
1

Similar Publications

A rare case of extrapulmonary hamartoma on the visceral pleura treated by uniportal VATS: case report and literature review.

J Cardiothorac Surg

January 2025

Department of Thoracic Surgery, Ningbo No.2 Hospital, 41 Xibei Road, Ningbo, 315010, P. R. China.

Pulmonary hamartomas are common. However, extrapulmonary hamartomas on the Visceral Pleura are very rare. We treated a patient with a pulmonary nodule at the left lower lobe by uniportal video-assisted thoracoscopic wedge resection, which showed a yellow nodule located on the visceral pleura.

View Article and Find Full Text PDF

Background/aim: Lymphangioleiomyomatosis (LAM) belongs to the perivascular epithelioid cell tumor (PEComa) family. The relationship between LAM and tuberous sclerosis complex (TSC) is of particular concern in a subset of women with clinically occult LAM involving the pelvic lymph nodes. This study aimed to investigate the clinicopathological features of incidental nodal LAM detected during the surgical staging of gynecological tumors.

View Article and Find Full Text PDF

Small cell lung carcinoma metastatic to the stomach: Commonly overlooked, limited treatment options.

World J Gastroenterol

December 2024

Diagnostic and Molecular Pathology, The Ottawa Hospital and University of Ottawa, Ottawa K1H 8L6, Ontario, Canada.

Small cell lung carcinoma metastatic to the stomach, whether synchronous or metachronous, is a rare phenomenon accounting for < 0.5% of lung cancers. Hence it can be overlooked by clinicians resulting in delayed diagnosis.

View Article and Find Full Text PDF

Rationale: Small-cell undifferentiated carcinoma (SmCC), as an aggressive malignancy, are most commonly arising in lung. Extrapulmonary SmCC is rare. It was reported that SmCC accounts for only 0.

View Article and Find Full Text PDF

Delta-like Ligand 3 (DLL3) targeting therapies are promising in small cell lung cancer (SCLC) treatment. However, DLL3 expression in SCLC and other neuroendocrine neoplasms (NEN) is heterogeneous and not well characterized. We describe the landscape of DLL3 at the mRNA and protein levels across SCLC, large cell neuroendocrine carcinoma (LCNEC), and non-small cell lung cancer.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!